Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Burke

Showing results (941-950 of 1,065) with videos related to

Pageof 107
Sort By:
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Cell Death and Differentiation|November 10, 2021
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolutionAndreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
American Journal of Clinical Pathology|October 31, 2022
The Reemergence of MeaslesMary K Klassen-Fischer, Ann M Nelson, Ronald C Neafie, et al.
Chemical Communications (Cambridge, England)|June 9, 2020
An ethylene cross-bridged pentaazamacrocycle and its Cu<sup>2+</sup> complex: constrained ligand topology and excellent kinetic stabilityAnthony D Shircliff, Benjamin P Burke, Dustin J Davilla, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 InhibitorBarbara Czako, Yuting Sun, Timothy McAfoos, et al.
Pageof 107

Showing results (941-950 of 1,065) with videos related to

Sort By:
Pageof 107
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Cell Death and Differentiation|November 10, 2021
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolutionAndreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
American Journal of Clinical Pathology|October 31, 2022
The Reemergence of MeaslesMary K Klassen-Fischer, Ann M Nelson, Ronald C Neafie, et al.
Chemical Communications (Cambridge, England)|June 9, 2020
An ethylene cross-bridged pentaazamacrocycle and its Cu<sup>2+</sup> complex: constrained ligand topology and excellent kinetic stabilityAnthony D Shircliff, Benjamin P Burke, Dustin J Davilla, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 InhibitorBarbara Czako, Yuting Sun, Timothy McAfoos, et al.
Pageof 107